Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mark Smithers

Showing results (61-70 of 128) with videos related to

Pageof 13
Sort By:
Journal of Cancer Survivorship : Research and Practice|June 11, 2020
Anxiety and depression after diagnosis of high-risk primary cutaneous melanoma: a 4-year longitudinal studyVanessa L Beesley, Maria Celia B Hughes, B Mark Smithers, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 21, 2020
Patterns of Omega-3 and Omega-6 Fatty Acid Dietary Intake and Melanoma Thickness at DiagnosisYahya Mahamat-Saleh, Maria Celia B Hughes, Kyoko Miura, et al.
ANZ Journal of Surgery|April 23, 2016
Assessment of morbidity following regional nodal dissection in the axilla and groin for metastatic melanomaJane E Theodore, Adam J Frankel, Janine M Thomas, et al.
Journal of the American Academy of Dermatology|February 8, 2020
Prognostic implications of biopsy with tumor transection for patients with high-risk primary melanomaLena A von Schuckmann, Kiarash Khosrotehrani, Maria Celia B Hughes, et al.
International Journal of Clinical Oncology|September 2, 2005
Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatinBryan H Burmeister, Euan T Walpole, Elizabeth A Burmeister, et al.
The Australasian Journal of Dermatology|January 18, 2023
Conditional survival in patients with stage IB-IIIA melanoma undergoing sentinel node biopsy in Queensland: A longitudinal studyAlexander James Tedman, Upekha E Liyanage, Sharene Chong, et al.
ANZ Journal of Surgery|July 21, 2021
Contemporary management of locoregionally advanced melanoma in Australia and New Zealand and the role of adjuvant systemic therapyB Mark Smithers, Robyn P M Saw, David E Gyorki, et al.
Melanoma Research|June 28, 2019
IRF4 rs12203592*T/T genotype is associated with nodular melanomaJenna E Rayner, Erin K McMeniman, David L Duffy, et al.
Health and Quality of Life Outcomes|October 3, 2021
Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomyNorma B Bulamu, Ravi Vissapragada, Gang Chen, et al.
International Journal of Cancer|April 11, 2022
Hypothesised cutaneous sites of origin of stage III melanomas with unknown primary: A multicentre studyBethan Clayton, Ferhan Muneeb, Maria Celia B Hughes, et al.
Pageof 13

Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Journal of Cancer Survivorship : Research and Practice|June 11, 2020
Anxiety and depression after diagnosis of high-risk primary cutaneous melanoma: a 4-year longitudinal studyVanessa L Beesley, Maria Celia B Hughes, B Mark Smithers, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 21, 2020
Patterns of Omega-3 and Omega-6 Fatty Acid Dietary Intake and Melanoma Thickness at DiagnosisYahya Mahamat-Saleh, Maria Celia B Hughes, Kyoko Miura, et al.
ANZ Journal of Surgery|April 23, 2016
Assessment of morbidity following regional nodal dissection in the axilla and groin for metastatic melanomaJane E Theodore, Adam J Frankel, Janine M Thomas, et al.
Journal of the American Academy of Dermatology|February 8, 2020
Prognostic implications of biopsy with tumor transection for patients with high-risk primary melanomaLena A von Schuckmann, Kiarash Khosrotehrani, Maria Celia B Hughes, et al.
International Journal of Clinical Oncology|September 2, 2005
Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatinBryan H Burmeister, Euan T Walpole, Elizabeth A Burmeister, et al.
The Australasian Journal of Dermatology|January 18, 2023
Conditional survival in patients with stage IB-IIIA melanoma undergoing sentinel node biopsy in Queensland: A longitudinal studyAlexander James Tedman, Upekha E Liyanage, Sharene Chong, et al.
ANZ Journal of Surgery|July 21, 2021
Contemporary management of locoregionally advanced melanoma in Australia and New Zealand and the role of adjuvant systemic therapyB Mark Smithers, Robyn P M Saw, David E Gyorki, et al.
Melanoma Research|June 28, 2019
IRF4 rs12203592*T/T genotype is associated with nodular melanomaJenna E Rayner, Erin K McMeniman, David L Duffy, et al.
Health and Quality of Life Outcomes|October 3, 2021
Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomyNorma B Bulamu, Ravi Vissapragada, Gang Chen, et al.
International Journal of Cancer|April 11, 2022
Hypothesised cutaneous sites of origin of stage III melanomas with unknown primary: A multicentre studyBethan Clayton, Ferhan Muneeb, Maria Celia B Hughes, et al.
Pageof 13